Back
Norfolk Southern 10K Form
Sell
34
NSC
Norfolk Southern
Last Price:
$237.67
Seasonality Move:
4.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | NSC/Norfolk Southern Quarterly |
2024-02-05 | 10K | NSC/Norfolk Southern Annual |
2023-10-25 | 10Q | NSC/Norfolk Southern Quarterly |
2023-07-27 | 10Q | NSC/Norfolk Southern Quarterly |
2023-04-26 | 10Q | NSC/Norfolk Southern Quarterly |
2023-02-03 | 10K | NSC/Norfolk Southern Annual |
Receive NSC News And Ratings
See the #1 stock for the next 7 days that we like better than NSC
NSC Financial Statistics
Sales & Book Value
Annual Sales: | $12.2B |
---|---|
Cash Flow: | $645M |
Price / Cash Flow: | 44.1 |
Annual Sales: | $60.93 |
Price / Book: | 3.87 |
Profitability
EPS (TTM): | 10.65000 |
---|---|
Net Income (TTM): | $2.4B |
Gross Margin: | $4.4B |
Return on Equity: | 18.67% |
Return on Assets: | 5.74% |
Norfolk Southern Earnings Forecast
Key Norfolk Southern Financial Ratios
-
The Gross Profit Margin over the past 40 years for NSC is 36.48%.
-
The Selling, General & Administrative Expenses for NSC have been equal to -0.53% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 39.52% of Operating Income.
-
The Net Earning history of NSC is 15.03% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 25 years.
Norfolk Southern Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Ground Transportation |
Sector: | Industrials |
Current Symbol: | NSC |
CUSIP: | 655844 |
Website: | norfolksouthern.com |
Debt
Debt-to-Equity Ratio: | 1.25 |
---|---|
Current Ratio: | 0.73 |
Quick Ratio: | 0.62 |
Price-to-Earnings
Trailing P/E Ratio: | 29.4 |
---|---|
Forward P/E Ratio: | 17.45 |
NSC Technical Analysis vs Fundamental Analysis
Sell
34
Norfolk Southern (NSC)
is a Sell
Is Norfolk Southern a Buy or a Sell?
-
Norfolk Southern stock is rated a SellThe current Norfolk Southern [NSC] share price is $235.77. The Score for NSC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.